What Are The Benefits Of Combing Artificial Intelligence (AI) And DNA-Encoded Libraries (DELs) For Drug Discovery?
AI is transforming the way discovery teams unlock value from DEL data. By pairing rich DNA-encoded library outputs with machine learning, researchers can reveal hidden patterns, expand chemical diversity, and accelerate the path to viable hits. A flexible, model‑driven platform ensures each target is analyzed with the right chemical representations and algorithms, automatically surfacing the strongest models for prediction. With this foundation, teams gain rapid access to more actionable starting points, lower experimental costs, and a faster route to compound ordering and validation.
Explore how integrated DEL expertise and AI innovation come together to streamline hit discovery and deliver more shots on goal.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.